Diagnostic Accuracy of a Specialized Pro Forma in Assessing Morbidly Adherent Placenta With Correlation to Intra-operative Findings
NCT ID: NCT04938050
Last Updated: 2022-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
21 participants
OBSERVATIONAL
2021-06-18
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Accuracy of Placental Thickness in Lower Uterine Segment Measured By Ultrasound in Prediction of Placenta Accreta Spectrum in Patients With Placenta Previa. A Diagnostic Test Accuracy Study
NCT05500404
Ultrasound in Prediction of Operative Findings in Cesarean Section Among Placenta Accreta Cases
NCT03286998
Morbidly Adherent Placenta, Diagnosis and Proper Management
NCT05307016
Surgical Classification of Abnormal Placentation
NCT02736058
The Accuracy Of 3D Color Ultrasonography for Detecting the Degree of Placenta Accreta Spectrum Invasion
NCT07250412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasound
Ultrasound evaluation, with grayscale and color Doppler imaging.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnant women in their late third trimester (34 0/7 weeks: 37 0/7 weeks).
* With a single living fetus in the current pregnancy.
* A previous delivery by at least 1 cesarean section or history of uterine surgery including (surgical evacuation, myomectomy or endometrium ablation)
* Having an anterior placenta previa or anterior low-lying placenta by ultrasound assessment.
Exclusion Criteria
* Maternal chronic medical disorders( diabetes mellitus, hypertension)
* Patients presented with severe attack of bleeding.
* Patients presented with rupture of membrane.
* Emergency delivery regardless the cause.
28 Years
42 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatma Fathy Hafez Ismail
Principle investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo university Kasr Alainy OBGYN hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.